Gastrointestinal stromal tumors in fine‐needle aspiration biopsies

Gastrointestinal stromal tumors (GISTs), although rare, are the most common mesenchymal neoplasms of the gastrointestinal tract. Their potential for malignancy underscores the significance of identifying them through cytomorphologic findings and pertinent immunohistochemical markers. GISTs can emerg...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic cytopathology 2024-10, Vol.52 (10), p.575-581
Main Authors: Mousavi, Seyedreza, Ono, Yuho, VanderLaan, Paul A., Guzmán‐Arocho, Yaileen D.
Format: Article
Language:English
Subjects:
Biomarkers, Tumor - metabolism
Biopsy, Fine-Needle
cytomorphology
Diagnosis, Differential
differential diagnosis
Female
Gastrointestinal cancer
Gastrointestinal Neoplasms - diagnosis
Gastrointestinal Neoplasms - pathology
gastrointestinal stromal tumor
Gastrointestinal Stromal Tumors - diagnosis
Gastrointestinal Stromal Tumors - pathology
GIST
Humans
immunohistochemistry
Male
molecular alterations
Proto-Oncogene Proteins c-kit - genetics
Proto-Oncogene Proteins c-kit - metabolism
targeted therapy
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gastrointestinal stromal tumors (GISTs), although rare, are the most common mesenchymal neoplasms of the gastrointestinal tract. Their potential for malignancy underscores the significance of identifying them through cytomorphologic findings and pertinent immunohistochemical markers. GISTs can emerge anywhere along the gastrointestinal tract with a predilection for the stomach. The clinical manifestations vary from nonspecific abdominal symptoms to incidental discovery during diagnostic interventions for unrelated signs and symptoms. Cytologically, GIST aspirates contain spindle or epithelioid cells with immunoreactivity for CD117/c‐KIT, DOG‐1, and CD34. Molecularly, KIT or PDGFRA mutations are prevalent, guiding targeted therapy with tyrosine kinase inhibitors. Distinct subtypes like succinate dehydrogenase‐deficient GISTs pose challenges, often affecting younger individuals and displaying unique features. Histologically, GISTs are graded by mitotic rates, aiding prognostication. Distinguishing GISTs from similar entities is pivotal, necessitating attention to their immunostaining patterns for making an accurate diagnosis and molecular alterations for effectively planning treatment. Common differential diagnoses include leiomyoma, schwannoma, and solitary fibrous tumor. This article presents a classic GIST case and showcases relatively simple diagnostic clues for identifying similar lesions that may occur in diverse locations.
ISSN:8755-1039
1097-0339
1097-0339
DOI:10.1002/dc.25285